Article thumbnail

Hydrolysis and transglycosylation reactions using SG-oxazoline as donor substrates by Endo-S mutants.

By Mitsuhiro Iwamoto (2680564), Yukiko Sekiguchi (4885450), Kensuke Nakamura (2989272), Yoshirou Kawaguchi (4885447), Takeshi Honda (150171) and Jun Hasegawa (159270)


<p>(A) Hydrolysis reactions were performed using trastuzumab and Endo-S mutants at a 50:1 weight ratio. (B) Transglycosylation reactions were carried out using deglycosylated trastuzumab as the acceptor and 5 molar eq of donor oxazoline.</p

Topics: Biophysics, Biochemistry, Medicine, Microbiology, Genetics, Biotechnology, Infectious Diseases, Space Science, Biological Sciences not elsewhere classified, Chemical Sciences not elsewhere classified, mutant, Endo-S D 233Q D 233Q, endoglycosidase, mutation, oxazoline, efficiency, glycan, D 233Q, Streptococcus pyogenes, novel one-pot transglycosylation reaction, transglycosylation efficiencies, antibody
Year: 2018
DOI identifier: 10.1371/journal.pone.0193534.g001
OAI identifier:
Provided by: FigShare
Download PDF:
Sorry, we are unable to provide the full text but you may find it at the following location(s):
  • (external link)
  • Suggested articles

    To submit an update or takedown request for this paper, please submit an Update/Correction/Removal Request.